Alwin has over 7 years of experience applying ML to drug discovery, including 3.5 years focused on method development and application of co-folding models in discovery programs at CHARM Therapeutics. At Apheris, he is working on advancing co-folding model architectures and training strategies across distributed datasets to maximize AI model improvements.